We gratefully acknowledge support from
the Simons Foundation and member institutions.
Full-text links:

Download:

Current browse context:

q-bio.TO

Change to browse by:

References & Citations

Bookmark

(what is this?)
CiteULike logo BibSonomy logo Mendeley logo del.icio.us logo Digg logo Reddit logo ScienceWISE logo

Quantitative Biology > Tissues and Organs

Title: Concanavalin A-targeted mesoporous silica nanoparticles for infection treatment

Abstract: The ability of bacteria to form biofilms hinders any conventional treatment against chronic infections and has serious socio-economic implications. In this sense, a nanocarrier capable of overcoming the barrier of the mucopolysaccharide matrix of the biofilm and releasing its loaded-antibiotic within would be desirable. Herein, a new nanosystem based on levofloxacin (LEVO)-loaded mesoporous silica nanoparticles (MSNs) decorated with lectin Concanavalin A (ConA) has been developed. The presence of ConA promotes its internalization into the biofilm matrix, which increases the antimicrobial efficacy of the antibiotic hosted within the mesopores. This nanodevice is envisioned as a promising alternative to conventional infection treatments by improving the antimicrobial efficacy and reducing side effects.
Comments: 27 pages, 9 figures
Subjects: Tissues and Organs (q-bio.TO); Biological Physics (physics.bio-ph)
Journal reference: Acta Biomaterialia. 96, 547-556 (2019)
DOI: 10.1016/j.actbio.2019.07.001
Cite as: arXiv:2103.07233 [q-bio.TO]
  (or arXiv:2103.07233v1 [q-bio.TO] for this version)

Submission history

From: María Vallet-Regi [view email]
[v1] Fri, 12 Mar 2021 12:20:28 GMT (636kb)

Link back to: arXiv, form interface, contact.